Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 11Breast 7Thoracic 5Gynecologic 5Tumor-Agnostic 2Other 2Head & Neck 2Plasma cell 1Genitourinary 1

Conditions

Neoplasms, Second Primary 1Neoplasms 1

Interventions

pembrolizumab 94Paclitaxel 85Gemcitabine 83Carboplatin 79Docetaxel 60Cisplatin 58Bevacizumab 58Nivolumab 56Fluorouracil 47Capecitabine 46Magnetic Resonance Spectroscopy 44Radiotherapy 41Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 37Pemetrexed 34Leucovorin 34Biopsy 34atezolizumab 33Cetuximab 32Standard of Care 31Trastuzumab 28Cyclophosphamide 28Radiosurgery 27Blood Specimen Collection 27Specimen Handling 26Sorafenib 26Ipilimumab 26Everolimus 26olaparib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Probiotics × Tumor-Agnostic × Clear all
NCT06998823 2025-05-31

The Effect of Survival, Response and Microbiota Change in Different Therapy Under Probiotic Supplement

Chang Gung Memorial Hospital

Phase NA Recruiting
120 enrolled
Tumor-Agnostic

Neoplasms, Second Primary

NCT01706393 2013-04-19

RTxIMprobio

Seoul National University Hospital

Phase NA Unknown
26 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡